Literature DB >> 18813052

A rational approach to perioperative fluid management.

Daniel Chappell1, Matthias Jacob, Klaus Hofmann-Kiefer, Peter Conzen, Markus Rehm.   

Abstract

Replacement of assumed preoperative deficits, in addition to generous substitution of an unsubstantiated increased insensible perspiration and third space loss, plays an important role in current perioperative fluid regimens. The consequence is a positive fluid balance and weight gain of up to 10 kg, which may be related to severe complications. Because the intravascular blood volume remains unchanged and insensible perspiration is negligible, the fluid must accumulate inside the body. This concept brings into question common liberal infusion regimens. Blood volume after fasting is normal, and a fluid-consuming third space has never been reliably shown. Crystalloids physiologically load the interstitial space, whereas colloidal volume loading deteriorates a vital part of the vascular barrier. The endothelial glycocalyx plays a key role and is destroyed not only by ischemia and surgery, but also by acute hypervolemia. Therefore, undifferentiated fluid handling may increase the shift toward the interstitial space. Using the right kind of fluid in appropriate amounts at the right time might improve patient outcome.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18813052     DOI: 10.1097/ALN.0b013e3181863117

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  165 in total

1.  Continuous minimally invasive peri-operative monitoring of cardiac output by pulmonary capnotracking: comparison with thermodilution and transesophageal echocardiography.

Authors:  Philip J Peyton
Journal:  J Clin Monit Comput       Date:  2012-02-18       Impact factor: 2.502

2.  Haematocrit is invalid for estimating red cell volume: a prospective study in male volunteers.

Authors:  Matthias Jacob; Simon Annaheim; Urs Boutellier; Christian Hinske; Markus Rehm; Christian Breymann; Alexander Krafft
Journal:  Blood Transfus       Date:  2012-05-04       Impact factor: 3.443

Review 3.  Perioperative fluid and electrolyte management in cardiac surgery: a review.

Authors:  Robert Young
Journal:  J Extra Corpor Technol       Date:  2012-03

Review 4.  [Postoperative wound infections. Pathophysiology, risk factors and preventive concepts].

Authors:  T Hachenberg; M Sentürk; O Jannasch; H Lippert
Journal:  Anaesthesist       Date:  2010-09       Impact factor: 1.041

5.  An in-vitro comparison between Hemobag and non-Hemobag ultrafiltration methods of salvaging circuit blood following cardiopulmonary bypass.

Authors:  Ed Delaney; David Rosinski; Harvey Ellis; Keith A Samolyk; Jeffrey B Riley
Journal:  J Extra Corpor Technol       Date:  2010-06

Review 6.  Pulse pressure variation: where are we today?

Authors:  Maxime Cannesson; Mateo Aboy; Christoph K Hofer; Mohamed Rehman
Journal:  J Clin Monit Comput       Date:  2011-02       Impact factor: 2.502

Review 7.  The impact of fluid therapy on microcirculation and tissue oxygenation in hypovolemic patients: a review.

Authors:  Joachim Boldt; Can Ince
Journal:  Intensive Care Med       Date:  2010-05-26       Impact factor: 17.440

8.  When sepsis affects the heart: A case report and literature review.

Authors:  Giuseppe Clemente; Antonino Tuttolomondo; Daniela Colomba; Rosaria Pecoraro; Chiara Renda; Vittoriano Della Corte; Carlo Maida; Irene Simonetta; Antonio Pinto
Journal:  World J Clin Cases       Date:  2015-08-16       Impact factor: 1.337

9.  Understanding Off-Label Use and Reference Blood Flows in Modern Membrane Oxygenators.

Authors:  Gerard J Myers
Journal:  J Extra Corpor Technol       Date:  2014-09

10.  Evaluation of the effect of intra-operative intravenous fluid on post-operative pain and pulmonary function: a randomized trial comparing 10 and 30 ml kg(-1) of crystalloid.

Authors:  B D Straub; A Aslani; K Enohumah; R Rahore; I Conrick-Martin; D Kumar; M Campbell; P Dicker; E Mocanu; J P Loughrey; N E Hayes; C L McCaul
Journal:  Ir J Med Sci       Date:  2013-12-10       Impact factor: 1.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.